Rapid and durable complete remission of refractory AITL with azacitidine treatment in absence of TET2 mutation or concurrent MDS

Gareth Gregory, Michael J Dickinson, Costas Yannakou, Jonathan Wong, Piers A. Blombery, Greg Corboy, Lev Kats, Timothy Crozier, Beena Kumar, Miles Prince, Stephen S Opat, Jake Shortt

Research output: Contribution to journalArticleOtherpeer-review

3 Citations (Scopus)
Original languageEnglish
Article numbere187
Number of pages4
JournalHemaSphere
Volume3
Issue number2
DOIs
Publication statusPublished - Apr 2019

Keywords

  • T cell
  • Azacitidine
  • angioimmunoblastic
  • TET2
  • Refractory
  • Lymphoma
  • Remission

Cite this